Gene · 382
Papers3,632
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,632
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Abnormalities in BTBR Mice and Their Relevance to Schizophrenia and Autism Spectrum Disorders: An Overview of Transcriptomic and Proteomic Studies. | Biomedicines | 2023 | 36830826 | PubTator, text mining | PubMed |
| Functional Relevance of the Long Intergenic Non-Coding RNA Regulator of Reprogramming (Linc-ROR) in Cancer Proliferation, Metastasis, and Drug Resistance. | Noncoding RNA | 2023 | 36827545 | PubTator, text mining | PubMed |
High‑throughput screening identification of a small‑molecule compound that induces ferroptosis and attenuates the invasion and migration of hepatocellular carcinoma cells by targeting the STAT3/GPX4 axis. | Int J Oncol | 2023 | 36825585 | PubTator, text mining | PubMed |
| ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma. | BMC Gastroenterol | 2023 | 36823542 | PubTator, text mining | PubMed |
| Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading. | Mol Ther | 2023 | 36805147 | PubTator, text mining | PubMed |
| Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer. | Heliyon | 2023 | 36798768 | PubTator, text mining | PubMed |
| Magnetic transferrin nanoparticles (MTNs) assay as a novel isolation approach for exosomal biomarkers in neurological diseases. | Biomater Res | 2023 | 36797805 | PubTator, text mining | PubMed |
| Current Strategies for Promoting the Large-scale Production of Exosomes. | Curr Neuropharmacol | 2023 | 36797614 | PubTator, text mining | PubMed |
| Neural stem/progenitor cell-derived extracellular vesicles: A novel therapy for neurological diseases and beyond. | MedComm (2020) | 2023 | 36776763 | PubTator, text mining | PubMed |
| Preclinical-to-clinical Anti-cancer Drug Response Prediction and Biomarker Identification Using TINDL. | Genomics Proteomics Bioinformatics | 2023 | 36775056 | PubTator, text mining | PubMed |
| Insights of Endocytosis Signaling in Health and Disease. | Int J Mol Sci | 2023 | 36769293 | PubTator, text mining | PubMed |
| Microbiota-Associated HAF-EVs Regulate Monocytes by Triggering or Inhibiting Inflammasome Activation. | Int J Mol Sci | 2023 | 36768851 | PubTator, text mining | PubMed |
| Interaction between Long Noncoding RNAs and Syncytin-1/Syncytin-2 Genes and Transcripts: How Noncoding RNAs May Affect Pregnancy in Patients with Systemic Lupus Erythematosus. | Int J Mol Sci | 2023 | 36768581 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Pulmonary Diseases: Comparison of Different Airway-Derived Biosamples. | Int J Mol Sci | 2023 | 36768329 | PubTator, text mining | PubMed |
| Inhibition of Macropinocytosis Enhances the Sensitivity of Osteosarcoma Cells to Benzethonium Chloride. | Cancers (Basel) | 2023 | 36765917 | PubTator, text mining | PubMed |
| Exosomal LncRNAs in Gastrointestinal Cancer: Biological Functions and Emerging Clinical Applications. | Cancers (Basel) | 2023 | 36765913 | PubTator, text mining | PubMed |
| Context-specific regulation of extracellular vesicle biogenesis and cargo selection. | Nat Rev Mol Cell Biol | 2023 | 36765164 | PubTator, text mining | PubMed |
| The small molecule inhibitor NAV-2729 has a complex target profile including multiple ADP-ribosylation factor regulatory proteins. | J Biol Chem | 2023 | 36758799 | PubTator, text mining | PubMed |
| Extracellular vesicle RNA signaling in the liver tumor microenvironment. | Cancer Lett | 2023 | 36758739 | PubTator, text mining | PubMed |
| A defined clathrin-mediated trafficking pathway regulates sFLT1/VEGFR1 secretion from endothelial cells. | bioRxiv | 2023 | 36747809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/382/papers?page=23